GPR183 gene a novel drug target for severe COVID-19 - News-Medical.Net


6/16/2022 12:00:00 AM2 years 10 months ago

In a recent study posted to the bioRxiv* pre-print server, researchers provide the first preclinical evidence of the usefulness of antagonists of G-protein coupled receptor 183 (GPR183), also known as Epstein-Barr virus-induced gene 2 (EBI2), in reducing coro…

In a recent study posted to the bioRxiv* pre-print server, researchers provide the first preclinical evidence of the usefulness of antagonists of G-protein coupled receptor 183 (GPR183), also known a… [+6619 chars]

full article...